News from the healthcare data industry
Data demonstrates that intravenous ketamine is a rapid and robust treatment for depression. These results can inform clinical best practices and provide real-world evidence to advocate for better insurance coverage.January...
Real-world data from the PACIFIC-R trial (NCT03798535) evaluating durvalumab (Imfinizi) following chemoradiotherapy in patients with stage III, unresectable non–small cell lung cancer (NSCLC) provide evidence supporting the agent’s efficacy in...
CAMBRIDGE, Mass., Dec. 15, 2021 /PRNewswire/ — nference, the AI-driven health technology company, announced today publication of a peer-reviewed study in Med that analyzed Mayo Clinic based data with nference artificial intelligence (AI) software to...
December 11, 2021 09:35 AM Eastern Standard Time BEERSE, Belgium–(BUSINESS WIRE)–The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new analyses illustrating responses that first-line treatment with DARZALEX®▼ (daratumumab)-based...
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (“Takeda”) today announced the presentation of nine company-sponsored abstracts at the 63rd American Society of Hematology (ASH) Annual Meeting being held December 11-14,...
Dec 10, 2021 | Turna Ray NEW YORK – An evaluation of real-world BRCA1/2 testing patterns among triple-negative breast cancer patients has shown that African American women within four community health systems...
CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced six abstracts accepted for poster sessions at the 2021 San Antonio Breast Cancer Symposium (SABCS) taking place December...
December 07, 2021 07:00 AM Eastern Standard Time SAN DIEGO–(BUSINESS WIRE)–Radicle Science, a transformative healthtech B-corp validating natural products for the first time, announces initial findings from the Radicle ACES...
GuardantINFORM™ platform offers real-world evidence to identify unmet need for patients with advanced breast cancer December 06, 2021 08:05 AM Eastern Standard Time REDWOOD CITY, Calif.–(BUSINESS WIRE)–sGuardant Health, Inc. (Nasdaq: GH),...
SAN FRANCISCO, Dec. 06, 2021 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, presented five abstracts...